Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cesium ions (Cs+) are monovalent alkali metal cations that exhibit chemical properties similar to potassium ions (K+). Due to this similarity, cesium is readily absorbed by the human body and distributed into soft tissues, particularly muscle, via potassium transport mechanisms (CDC, 2018). While stable cesium is relatively non-toxic, radioactive isotopes such as Cesium-137 (137Cs) pose severe health risks as they emit beta and gamma radiation, increasing the risk of cancer and acute radiation syndrome (NIH, 2023). In clinical toxicology, cesium ions are the primary target for decorporation therapy using Prussian Blue (ferric hexacyanoferrate), which acts as an ion exchanger in the gut to trap cesium and prevent its enterohepatic recirculation (FDA, 2003). Furthermore, in laboratory settings, cesium is frequently utilized as a pharmacological tool to block potassium channels, thereby facilitating the study of other ionic currents in excitable cells (PubChem, 2024). Effective management of cesium exposure involves monitoring urinary excretion and ensuring the maintenance of electrolyte balance during treatment. This target is unique because the therapeutic intervention focuses on the removal of the ion from the body rather than modulating its biological signaling (StatPearls, 2023).
Ion exchange and sequestration within the gastrointestinal tract to prevent enterohepatic circulation and promote fecal excretion.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cesium ion (Cs+) (Cs+).